Accelerates Horizon's Transformation to a Profitable Specialty Pharma CompanyExpected Pro Forma Combined, Full Year 2014 Revenues of $250 to $265 Million and EBITDA(1) of $65 to $75 Million Vidara ...

Horizon Pharma, Inc. (NASDAQ: HZNP) and Vidara Therapeutics International Ltd. (Vidara) today announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara ...

In a bid to take advantage of low tax rates in Ireland, Horizon Pharma (NASDAQ:HZNP) unveiled plans on Wednesday to acquire Irish specialty drug maker Vidara in a $660 million cash-and-stock reverse ...

Yet another U.S. drugmaker is joining the growing list that has headed to Ireland to enjoy the tax benefits. The Chicago area-based Horizon Pharma ($HZNP) is doing a ...

Horizon Pharma said today it will buy Vidara Therapeutics International for about $660 million, in a deal the acquiring company said would speed up its repositioning into a specialty drug developer.

Dublin-based pharmaceutical company Vidara Therapeutics has been acquired by US drug giant Horizon Pharma in a deal worth $660 million (€474 million). The privately-owned firm, which employs 24 staff ...

Horizon Pharma, Inc., a commercial stage, specialty pharmaceutical company, and Vidara Therapeutics International Ltd. (Vidara) have entered into a definitive agreement under which Horizon Pharma will ...

DEERFIELD, Ill. (AP) — Horizon Pharma Inc. plans to buy the privately held Vidara Therapeutics International Ltd. in a cash-and-stock deal that will add the immune system disorder drug Actimmune to ...

Horizon Pharma Inc. agreed to acquire Vidara Therapeutics Inc. in a cash-and-stock deal valued at about $660 million, as the specialty pharmaceutical company sought to expand its range of products. As ...

DEERFIELD, IL and DUBLIN, IRELAND--(Marketwired - Mar 19, 2014) - Horizon Pharma, Inc. (HZNP) and Vidara Therapeutics International Ltd. (Vidara) today announced they have entered into a definitive ...

DUBLIN, IRELAND--(Marketwired - Sep 19, 2014) - Horizon Pharma (HZNP) announced today it has completed the acquisition of Vidara Therapeutics International plc. In connection with the acquisition, ...

Horizon Pharma, Inc. and Vidara Therapeutics International Ltd. today announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger ...